Celltrion Gets EC Approval for Avtozma® (CT-P47), Biosimilar to RoActemra®
Celltrion Gets EC Approval for Avtozma® (CT-P47), Biosimilar to RoActemra® Celltrion announced today that it has received marketing authorization from the European Commission (EC) for Avtozma® (CT-P47), a biosimilar referencing the reference biologic RoActemra® (tocilizumab). This approval allows Avtozma® to…
Hartford HealthCare Partners with K Health to Transform Primary Care
Hartford HealthCare Partners with K Health to Transform Primary Care Hartford HealthCare has partnered with K Health to revolutionize primary care delivery in Connecticut. The collaboration aims to redefine access to primary care using advanced clinical AI. As one of…
KalVista to Present New Sebetralstat Data at AAAAI 2025 Annual Meeting
KalVista to Present New Sebetralstat Data at AAAAI 2025 Annual Meeting KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) has announced that six of its abstracts have been accepted for presentation at the American Academy of Allergy, Asthma & Immunology (AAAAI) / World…
Iterative Health to Showcase AI Advancements at ECCO 2025 for Ulcerative Colitis Trials
Iterative Health to Showcase AI Advancements at ECCO 2025 for Ulcerative Colitis Trials Iterative Health, a healthcare technology and services company focused on advancing gastrointestinal care in partnership with physicians, will present five abstracts at the European Crohn’s & Colitis…
ReCerise Signs Research Collaboration for Innovative Hepatocellular Carcinoma Treatment
ReCerise Signs Research Collaboration for Innovative Hepatocellular Carcinoma Treatment ReCerise Therapeutics Inc., a company focused on developing first-in-class oncology therapeutics, has announced a new research partnership with the National Cancer Centre Singapore (NCCS). The collaboration aims to create innovative treatments…
Covalon Reports Fourth Straight Quarter of Revenue Growth and Positive Earnings
Covalon Reports Fourth Straight Quarter of Revenue Growth and Positive Earnings Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its financial results for the first quarter of fiscal 2025, ending December 31, 2024, alongside…
Claritev Delivers Actionable Insights for Oracle Cloud HCM Customers on Healthcare Cost Optimization
Claritev Delivers Actionable Insights for Oracle Cloud HCM Customers on Healthcare Cost Optimization Claritev Corporation (“Claritev” or the “Company”) (NYSE: MPLN), formerly known as MultiPlan, a leader in healthcare technology, data, and insights, announced that its BenInsights® platform has earned…
Sensorion Receives Positive Recommendation for Audiogene Trial of SENS-501
Sensorion Receives Positive Recommendation for Audiogene Trial of SENS-501 Sensorion, a clinical-stage biotechnology company focused on developing novel therapies to treat and prevent hearing loss, has announced a positive recommendation from the Data Monitoring Committee (DMC) for its Phase 1/2…
Waystar Prices Public Offering of Common Stock
Waystar Prices Public Offering of Common Stock Waystar Holding Corp. (Nasdaq: WAY), a leader in healthcare payments software, announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock, offered by certain investment funds of EQT…
Neuroendocrine Tumor Center of Excellence Re-Certified
Neuroendocrine Tumor Center of Excellence Re-Certified The Center for Neuroendocrine Tumors at the Bad Berka Central Clinic has been officially re-certified, continuing its distinction as a leading medical facility in the field. This center has been a certified European Center…
HealthStream’s LMS, HealthStream Learning Center®, Ranked #1 in G2’s 2025 Best Healthcare Software List
HealthStream’s LMS, HealthStream Learning Center®, Ranked #1 in G2’s 2025 Best Healthcare Software List HealthStream, Inc. (Nasdaq: HSTM), a leading technology platform for workforce solutions in healthcare, announced that its Learning Management System (LMS), the HealthStream Learning Center®, has been…
Veradigm Extends Stockholder Rights Plan
Veradigm Extends Stockholder Rights Plan Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, has announced that its Board of Directors has approved an amendment to extend the company’s existing Stockholder Rights Plan. This extension moves the…